Goldman Sachs Maintains Neutral Rating on Mitsui Chemicals; Raises 12-Month Target Price to ¥2,310

Overview

This report provides Goldman Sachs’ interpretation of the business briefing issued by Mitsui Chemicals (4183.T), a leading Japanese chemical company. Following the appointment of new CEO Satoshi Ichimura, the company has announced three core strategic pillars: accelerating portfolio transformation, expanding globally, and enhancing enterprise value through stakeholder engagement. Although management has demonstrated strong intent to transform, Goldman Sachs believes overall profit growth will remain lackluster in the near term due to challenging demand conditions and intense competition. Accordingly, Goldman Sachs maintains its 'Neutral' rating on Mitsui Chemicals. However, reflecting valuation roll-forward and adjustments to earnings forecasts, it modestly raises the 12-month target price from ¥2,240 to ¥2,310.

Core views

New Management Strategy and Short-Term Mitigation Measures: The new CEO emphasizes leveraging world-class products and technologies to position Mitsui Chemicals as a 'genuine global specialty company.' To operationalize this vision, the company has formed a cross-functional team comprising the CFO, CTO, and other senior executives, tasked with delivering a robust group-wide plan within 100 days. In response to raw material supply risks arising from Middle East tensions, the company has adopted three measures: (1) sourcing naphtha from non-Middle Eastern regions to secure stable supply; (2) implementing broad-based price increases to pass through rising raw material and fuel costs; and (3) deferring non-essential expenditures to preserve cash flow. Management reports having secured naphtha supply for the next two months and plans to raise operating rates starting in July. Performance and Outlook by Business Segment: In the Life & Healthcare Solutions segment, vision care operations experienced slower FY3/26 profit growth due to the gas leak incident at the Omuta plant, though stable medium-term growth is expected to resume. In crop protection, inventory adjustments in Brazil are weighing on performance, but sales growth of new products such as Tenebenal is expected to partially offset this pressure. The ICT Solutions segment performed strongly: ICROS Tape™ for semiconductor manufacturing benefited from expanded capacity at the Taiwan facility, and demand for dicing tapes used in HBM applications drove FY3/26 sales up ~20% YoY. However, recent demand for EUV photoresists remains weak; although yield improvements have been achieved, competitive dynamics around next-generation CNT photoresists warrant close monitoring. Earnings Forecast Revisions and Valuation: Reflecting lower utilization rates in the Basic & Green Materials (B&GM) business, across-the-board increases in raw material and fuel costs, and weakening demand for automotive materials, Goldman Sachs reduces its core operating profit forecasts for FY3/27 and FY3/28 by 13% and 8%, respectively. Nonetheless, by rolling the valuation benchmark from FY3/27E to an average of FY3/27E–FY3/28E and applying a cash return multiple of 0.7x (a 30% discount to the industry average) in its target price model, Goldman Sachs raises its 12-month target price from ¥2,240 to ¥2,310.

Analysis framework

Goldman Sachs’ analytical framework centers on balancing 'strategic transformation intent' against 'near-term financial realities.' First, it evaluates the feasibility and execution capability of the new CEO’s strategic direction—including global expansion and portfolio optimization—by interpreting the business briefing. Second, it analyzes actual operating performance and profitability across business segments—particularly high-growth ICT and stable healthcare—within the context of macro conditions (e.g., Middle East developments, raw material prices) and industry competitive dynamics. Finally, it applies relative valuation, referencing correlations between EV/GCI and CROCI/WACC in the materials sector, while incorporating the company’s capital return metrics (CROCI) and weighted average cost of capital (WACC) to derive the target price. This methodology captures both long-term transformation potential and short-term cyclical headwinds and cost pressures.

Methodology notes

• Valuation MethodEV/EBITDA valuation

  Valuation model based on correlations between EV/GCI and CROCI/WACC

  Goldman Sachs uses correlations between enterprise value-to-gross capital invested (EV/GCI) and cash return on capital invested relative to WACC (CROCI/WACC) to derive the target price. This relative valuation approach integrates capital efficiency and returns, enabling more accurate assessment of intrinsic value for capital-intensive chemical companies.

• Industry/Supply Chain FrameworkUpstream–Midstream–Downstream Transmission

  Mechanism of passing raw material cost increases to downstream pricing

  The report analyzes how rising naphtha and other raw material costs—triggered by Middle East tensions—are transmitted to end customers via price increases, and assesses the impact of such transmission on cash flow and margins. This perspective is critical in evaluating pricing power and earnings resilience in chemical industry analysis.

• Corporate Fundamentals & Financial FrameworkFree cash flow analysis

  Preserving free cash flow by deferring non-essential expenditures

  In response to external shocks, the company manages capital spending and operating costs to safeguard free cash flow—a key indicator for assessing financial safety margins during cyclical downturns or unexpected events.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Mitsui Chemicals (4183.T)

  Directly Covered Entity

  Strengths

  World-class products and technologies; strong growth in ICT Solutions; proactive portfolio transformation and global expansion led by new CEO.

  Weaknesses

  Basic & Green Materials business significantly affected by cyclical and cost pressures; near-term profit growth lacks momentum; certain M&A initiatives (e.g., ARRK) underperforming expectations.

  Comparison

  Valuation sits within a reasonable range relative to peers in the Japanese chemicals and advanced materials sector, though growth momentum remains temporarily subdued.

  Risks

  Raw material price volatility, slower-than-expected demand recovery, currency fluctuations, intensifying competition.

Key data

• 12-Month Target Price¥2,310Raised from ¥2,240, implying 4.8% upside
• FY3/27 Core Operating Profit Forecast RevisionDown 13%Driven by lower utilization in B&GM and rising costs
• FY3/28 Core Operating Profit Forecast RevisionDown 8%Driven by weakening demand for automotive materials
• ICT Solutions FY3/26 Sales Growth~+20% YoYBenefiting from rising demand for semiconductor manufacturing tapes
• WACC Assumption5%Used in valuation model

Impact & implications

The report concludes that while Mitsui Chemicals’ transformation initiative carries meaningful long-term strategic significance, investors should not expect robust near-term profit growth amid current challenging market conditions. The Neutral rating implies the stock’s current valuation already reasonably reflects its fundamentals and associated risks. For investors focused on the chemicals sector, key areas to monitor include the company’s progress in expanding in emerging markets and the ramp-up of high-value-added products—such as semiconductor materials—as these will be critical catalysts for future re-rating.

Risks

• Risk of rising or falling raw material costs (e.g., crude oil)
• Risk of improving or deteriorating market conditions
• Risk of JPY depreciation or appreciation
• Risk of easing or intensifying competitive environment
• Risk of unexpectedly slowing or accelerating demand

What to watch

• Inventory adjustment progress in Brazil’s crop protection business and sales recovery trajectory for new products such as Tenebenal
• Signs of recovery in EUV photoresist demand and evolving competitive landscape for next-generation CNT photoresists
• Milestones in restructuring the Basic & Green Materials business (e.g., integration of Chiba’s single ethylene cracker facility by FY3/28)
• Profitability of localized production models in emerging markets—particularly India and the U.S.